Co-author: Christopher Crowe

Unauthenticated ORCID logo https://orcid.org/0000-0002-2966-0665

Co-authored publications (2):

Anthony MS , Djebarri L , Beachler DC et al . Risk of anaphylaxis among new users of glucagon-like peptide-1 receptor agonists (GLP-1 ras) . Poster presented at: 2023 American Diabetes Association Scientific Sessions; June 23 - June 26, 2023; San Diego, CA, US . https://diabetesjournals.org/diabetes/article/72/Supplement_1/846-P/150217/846-P-Risk-of-Anaphylaxis-among-New-Users-of . doi: 10.2337/db23-846-P .
Anthony MS , Aroda VR , Parlett LE et al . Risk of anaphylaxis among new users of GLP-1 receptor agonists: a cohort study .Diabetes Care. 2024; 47 (4) : 712-9 . doi: 10.2337/dc23-1911 .

Disclaimer

The content of this website, including articles, papers, and any other materials, reflects my personal views and opinions. They do not necessarily represent the views or opinions of my employer, colleagues, or any affiliated organizations. Unless explicitly stated otherwise, this content was generated without the use of any generative AI or large language models (LLMs); all information presented here is solely the result of human input and research.

I may provide links to external websites for convenience or reference, but this does not constitute an endorsement of those sites or the content within them. I am not responsible for the content, accuracy, or reliability of any external websites.

All information shared on this website is for informational purposes only and should not be construed as professional advice.

site admin | credits